Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × brivanib × Clear all

NCT00355238 2023-12-01

A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer

Phase 2 Completed

137 enrolled 20 charts

Gastrointestinal

Carcinoma, Hepatocellular